Success Metrics

Clinical Success Rate

66.7%

Based on 2 completed trials

Completion Rate

67%(2/3)

Active Trials

1(25%)

Results Posted

50%(1 trials)

Terminated

1(25%)

Phase Distribution

Ph not_applicable

25%

Ph phase_4

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution2 total trials

Phase 4Post-market surveillance

1(50.0%)

N/ANon-phased studies

1(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(2)

Terminated(1)

Detailed Status

Completed2

Terminated1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

66.7%

Most Advanced

Phase 4

Trials by Phase

Phase 41 (50.0%)

N/A1 (50.0%)

Trials by Status

terminated125%

recruiting125%

completed250%

Recent Activity

1 active trials

Showing 4 of 4

recruiting

Correlating EEG Dynamics With Consciousness Alteration Under Anesthesia

NCT07410702

completednot_applicable

The Effect Of Positive End-Expiratory Pressure on Optic Nerve Sheath Diameter In Pediatric Patients Undergoing Craniotomy in Supine Position

NCT07370779

completed

Enzymatic Evaluation of General Anesthetic Induced Neurotoxicity in Patients With Aneurysmal Subarachnoid Hemorrhage

NCT03213392

terminatedphase_4

N-methyl-D-aspartate Antagonist (Ketamine) Augmentation of Electroconvulsive Treatment for Severe Major Depression

NCT01260649

Clinical Trials (4)

Showing 4 of 4 trials

NCT07410702

Correlating EEG Dynamics With Consciousness Alteration Under Anesthesia

Recruiting

NCT07370779Not Applicable

The Effect Of Positive End-Expiratory Pressure on Optic Nerve Sheath Diameter In Pediatric Patients Undergoing Craniotomy in Supine Position

Completed

NCT03213392

Enzymatic Evaluation of General Anesthetic Induced Neurotoxicity in Patients With Aneurysmal Subarachnoid Hemorrhage

Completed

NCT01260649Phase 4

N-methyl-D-aspartate Antagonist (Ketamine) Augmentation of Electroconvulsive Treatment for Severe Major Depression

Terminated

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4